Didemnins and Ustiloxins as Probes of Cell Proliferation
德德宁和乌斯蒂洛辛作为细胞增殖的探针
基本信息
- 批准号:7385154
- 负责人:
- 金额:$ 31.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-09-30 至 2010-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffinityAntimitotic AgentsAntineoplastic AgentsAreaAziridinesBindingBinding ProteinsBiochemicalBiologicalBiological FactorsCell Cycle StageCell ProliferationCell Proliferation RegulationCell membraneCellsClassCloningCollectionCyclic PeptidesDepsipeptidesDevelopmentDidemnin BEvaluationFamilyGenerationsHuman Cell LineHybridsImageImmunosuppressive AgentsInvestigationKnowledgeMarinesMethodologyMethodsModelingMolecularNitrogenPeptidesPlantsPreparationProteomicsPurposeReactionRoleRouteStructureSynthesis ChemistrySystemTubulinUrochordataValidationanaloganalytical toolascidianaziridinebasecell typecellular imagingchemical synthesiscytotoxicitydesigndidemnin Adidemninsimprovedin vivomarine natural productnovelphomopsinprogramsreceptorscaffoldsoundstereochemistrytamandarin Btooltwo-photonustiloxin Austiloxin D
项目摘要
DESCRIPTION (provided by applicant): This is a renewal application of our 17th-year program (CA-40081) focusing on the total synthesis of cyclic peptide and depsipeptides with potent regulation of cell proliferation. Our studies have focused on 2 classes of natural products the didemnin/tamandarin depsipeptides from marine ascidians (tunicates) and the ustiltoxin/phomopsin heterodetic peptides of plant origin. Our approach develops total synthesis of families of natural products as tools for SAR and proteomic analyses. Our previous program has considerably advanced the synthetic chemistry of the tunicate metabolites and established unequivocally the structural similarity and biological activity of didemnin/tamandarin depsipeptides. New initiatives in this area will investigate the subpicomolar immunosuppressive activity of didemnin M and tamandarin M. Probe molecules designed on the tamandarin scaffold will be synthesized using advanced routes for biochemical investigations. Second generation fluorescent and affinity analogs of the tamandarins, are being prepared to untangle the relationships among the different types of activity. In vivo cell analyses have been combined with a rigorous proteomics approach to elucidate the molecular receptors for these depsipeptides. Using a refined approach, we continue our efforts towards understanding marine natural products by developing a comprehensive analysis of the activity, target and synthesis of an entire class of natural products. In a second set of studies, we have applied our class based approach to a set of tubulin regulators, the ustiloxins and phomopsins. We have demonstrated the ability to achieve facile syntheses of the ustiloxins, and now offer a sound platform for development of accurate methods for analog and congener preparation. Ongoing studies are now underway to transfer the knowledge gained through our analogs and derivatives to provide a comprehensive model for the SAR and biological activities of these heterodetic peptides.
描述(由申请人提供):这是我们第17年项目(CA-40081)的更新申请,重点是具有有效调节细胞增殖的环肽和沉积肽的总合成。我们的研究主要集中在两类天然产物,即来自海洋海鞘动物(被囊动物)的海鞘素/毛檀素沉积肽和来自植物的海鞘毒素/毛檀素异源肽。我们的方法开发了天然产物家族的全合成,作为SAR和蛋白质组学分析的工具。我们之前的项目已经在很大程度上推进了被囊动物代谢物的合成化学,并明确地建立了dididmin /tamandarin沉积肽的结构相似性和生物活性。在这一领域,新的研究方向将是研究红皮素M和红皮素M的亚皮摩尔免疫抑制活性。在红皮素支架上设计探针分子将采用先进的途径进行生化研究。第二代荧光和亲和类似物的红皮苷,正准备解开不同类型的活动之间的关系。体内细胞分析已经结合了严格的蛋白质组学方法来阐明这些沉积肽的分子受体。通过一种精细的方法,我们通过对一整类天然产品的活性、目标和合成进行全面分析,继续努力了解海洋天然产品。在第二组研究中,我们将基于类的方法应用于一组微管蛋白调节剂,ustiloxins和phoomopsin。我们已经证明了实现ustiloxins的快速合成的能力,现在为开发类似物和同系物制备的精确方法提供了一个良好的平台。目前正在进行的研究正在转移通过我们的类似物和衍生物获得的知识,为这些异源肽的SAR和生物活性提供一个全面的模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MADELEINE M JOULLIE其他文献
MADELEINE M JOULLIE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MADELEINE M JOULLIE', 18)}}的其他基金
Didemnins and Ustiloxins as Probes of Cell Proliferation
德德宁和乌斯蒂洛辛作为细胞增殖的探针
- 批准号:
7845468 - 财政年份:2009
- 资助金额:
$ 31.68万 - 项目类别:
SYNTHESIS OF BIOLOGICALLY ACTIVE CYCLODEPSIPEPTIDES
生物活性环缩肽的合成
- 批准号:
2090102 - 财政年份:1985
- 资助金额:
$ 31.68万 - 项目类别:
SYNTHESIS AND CONFORMATIONAL STUDIES OF DIDEMNINS A, B
地德米宁 A、B 的合成及构象研究
- 批准号:
3179572 - 财政年份:1985
- 资助金额:
$ 31.68万 - 项目类别:
SYNTHESIS AND CONFORMATIONAL STUDIES OF DIDEMNINS A, B
地德米宁 A、B 的合成及构象研究
- 批准号:
3179571 - 财政年份:1985
- 资助金额:
$ 31.68万 - 项目类别:
DIDEMNINS--SYNTHETIC STUDIES AND MECHANISM OF ACTION
Didemnins--综合研究和作用机制
- 批准号:
2683442 - 财政年份:1985
- 资助金额:
$ 31.68万 - 项目类别:
DIDEMNINS AND USTILOXINS AS PROBES OF CELL PROLIFERATION
地德米宁和乌斯蒂洛辛作为细胞增殖的探针
- 批准号:
6512349 - 财政年份:1985
- 资助金额:
$ 31.68万 - 项目类别:
DIDEMNINS--SYNTHETIC STUDIES AND MECHANISM OF ACTION
Didemnins--综合研究和作用机制
- 批准号:
2894635 - 财政年份:1985
- 资助金额:
$ 31.68万 - 项目类别:
DIDEMNINS--SYNTHETIC STUDIES AND MECHANISM OF ACTION
Didemnins--综合研究和作用机制
- 批准号:
2873319 - 财政年份:1985
- 资助金额:
$ 31.68万 - 项目类别:
SYNTHESIS OF BIOLOGICALLY ACTIVE CYCLODEPSIPEPTIDES
生物活性环缩肽的合成
- 批准号:
3179573 - 财政年份:1985
- 资助金额:
$ 31.68万 - 项目类别:
DIDEMNINS--SYNTHETIC STUDIES AND MECHANISM OF ACTION
Didemnins--综合研究和作用机制
- 批准号:
6038364 - 财政年份:1985
- 资助金额:
$ 31.68万 - 项目类别:
相似海外基金
A novel bioassay system for antimitotic agents using unicellular organisms
使用单细胞生物体的新型抗有丝分裂剂生物测定系统
- 批准号:
25560416 - 财政年份:2013
- 资助金额:
$ 31.68万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
APOPTOSIS-INDUCING ANTIMITOTIC AGENTS FOR CANCER THERAPY
用于癌症治疗的细胞凋亡诱导抗有丝分裂剂
- 批准号:
6298857 - 财政年份:2001
- 资助金额:
$ 31.68万 - 项目类别:
STUDIES ON THE ANTIMITOTIC AGENTS-TUBULIN INTERACTION AND DRUG DESIGN
抗有丝分裂剂-微管蛋白相互作用及药物设计的研究
- 批准号:
08407070 - 财政年份:1996
- 资助金额:
$ 31.68万 - 项目类别:
Grant-in-Aid for Scientific Research (A)